Collaboration Is Key in Effort to Find a COVID-19 Vaccine

Vaccine manufacturers have agreed to work together by sharing information and their clinical trial databases in the race to create an effective COVID-19 vaccine. The effort will include 100,000 volunteers and approximately six vaccine candidates that have evidence demonstrating their safety. Starting in July, large-scale trials of the selected vaccines will begin among medical personnel and in areas that are still experiencing outbreaks of the novel coronavirus. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership between private manufacturers and the United States government, the endeavor could lead to the availability of an effective vaccine by the end of the year. All vaccine candidates will be tested for disease enhancement, in which a vaccine worsens the effects of disease instead of preventing it. Read more here.